These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2504852)

  • 1. [Polycystic ovary syndrome in a patient undergoing maintenance hemodialysis].
    Tanaka Y; Nagao M; Nishio T; Matsumoto J; Hashida E; Kashiwagi A; Shigeta Y
    Nihon Naika Gakkai Zasshi; 1989 May; 78(5):690-1. PubMed ID: 2504852
    [No Abstract]   [Full Text] [Related]  

  • 2. Luteinizing hormone, adrenal androgenesis, and polycystic ovarian disease.
    Polansky S
    Obstet Gynecol; 1975 Apr; 45(4):451-4. PubMed ID: 1121374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and pathogenesis of polycystic ovary syndrome].
    Lin SQ
    Zhonghua Yi Xue Za Zhi; 1983 Jul; 63(7):447-52. PubMed ID: 6416651
    [No Abstract]   [Full Text] [Related]  

  • 4. A possible role for familial thrombophilia in women with polycystic ovarian syndrome.
    Moini A; Sarrafion F; Ziaei S; Faghihzadeh S; Arabipoor A
    Gynecol Endocrinol; 2011 Feb; 27(2):80-5. PubMed ID: 21231824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis of polycystic ovary syndrome].
    Koreneva GP; Shikaeva FV; Efimenko NF
    Akush Ginekol (Mosk); 1982 Feb; (2):21-3. PubMed ID: 6805352
    [No Abstract]   [Full Text] [Related]  

  • 6. [Circulating levels of LH, FSH and basal steroids in subjects with polycystic ovary syndrome before and after wedge resection of the ovaries].
    Ragucci N; Amato G; Izzo A
    Arch Ostet Ginecol; 1981; 86(5-6):263-79. PubMed ID: 6819842
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ovarian wedge resection for polycystic ovary syndrome: analysis of 28 cases].
    Zhu RL
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):290-3, 319. PubMed ID: 3936686
    [No Abstract]   [Full Text] [Related]  

  • 8. Subclinical hypothyroidism: a determinant of polycystic ovary syndrome.
    Ghosh S; Kabir SN; Pakrashi A; Chatterjee S; Chakravarty B
    Horm Res; 1993; 39(1-2):61-6. PubMed ID: 8406342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cytogenetic studies of patients with polycystic ovary disease.
    Parker R; Ming PM; Rajan R; Goodner DM; Remé G
    Am J Obstet Gynecol; 1980 Jul; 137(6):656-60. PubMed ID: 6772030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The hormonal profile in the polycystic ovary syndrome].
    Donát J; Kohoutek M; Donátová N; Lacinová V
    Cesk Gynekol; 1989 Nov; 54(9):684-8. PubMed ID: 2516481
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenesis of polycystic ovarian disease.
    James R; Givens MD
    Acta Eur Fertil; 1979 Sep; 10(3):89-103. PubMed ID: 121017
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of dexamethasone on blood levels of FSH, LH, PRL and testosterone in patients with Stein-Leventhal syndrome before and after wedge resection of the ovaries].
    Zieleniewski J; Reterski Z; Owczarczyk I
    Ginekol Pol; 1982; 53(7-8):505-10. PubMed ID: 6820647
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of ultrasound and Doppler analysis in the diagnosis of polycystic ovary syndrome.
    Battaglia C
    Ultrasound Obstet Gynecol; 2003 Sep; 22(3):225-32. PubMed ID: 12942492
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for the hypothalamic origin of the polycystic ovary syndrome.
    Wortsman J; Singh KB; Murphy J
    Obstet Gynecol; 1981 Aug; 58(2):137-41. PubMed ID: 6454866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of the antiserotoninergic preparation cyproheptadine on the levels of luteinizing and follicle-stimulating hormones and testosterone in patients with polycystic ovaries].
    Tudose TI
    Probl Endokrinol (Mosk); 1987; 33(3):22-5. PubMed ID: 3116528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood levels of gonadotropins and gonadal hormones in gynecomastia associated with chronic hemodialysis.
    Sawin CT; Longcope C; Schmitt GW; Ryan RJ
    J Clin Endocrinol Metab; 1973 May; 36(5):988-90. PubMed ID: 4698251
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal correlations in the polycystic ovary syndrome.
    Messina M; Milani P; Gentile L
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):31-5. PubMed ID: 3087390
    [No Abstract]   [Full Text] [Related]  

  • 19. Polycystic ovary disease in two patients with Briquet's disorder.
    Orenstein H; Raskind MA
    Am J Psychiatry; 1983 Sep; 140(9):1202-4. PubMed ID: 6412573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
    Daane TA; Dignam WJ; Frankland MV; Simmer HH; Parlow AF
    Am J Obstet Gynecol; 1973 Oct; 117(3):392-9. PubMed ID: 4729733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.